Cimetidine
Back to searchMolecule Structure
Scientific Name
Cimetidine
Description of the Drug
Cimetidine is a histamine H2 receptor antagonist used to manage GERD, peptic ulcer disease, and indigestion.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00501
http://www.drugbank.ca/drugs/DB00501
Brand Name(s)
Acid-eze, Acitak 200, Acitak 400, Acitak 800, Brumetadina, Cimetidine, Dyspamet, Galenamet, Kentamet, Peptimax 200, Peptimax 400, Peptimax 800, Tagadine, Tagamet, Tagamet 100, Tagamet hb, Tagamet hb 200, Ultec, Valmagen, Zita
Company Owner(s)
Dava Pharmaceuticals Inc, Glaxosmithkline, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Hospira Worldwide, Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Novitium Pharma Llc, Akorn Operating Co Llc, Hikma Pharmaceuticals International Ltd, Chartwell Molecular Holdings Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1941 |
Clinical Trial(s)
Unichem Links
| Atlas | cimetidine | |||
| SureChEMBL | SCHEMBL1093 | |||
| PharmGKB | PA449001 | |||
| Human Metabolome Database | HMDB0014644 | |||
| DrugBank | DB00501 | |||
| PubChem: Thomson Pharma | 14774387 | 15122273 | 15196790 | |
| PubChem | 2756 | |||
| Mcule | MCULE-2885245608 | |||
| LINCS | LSM-2404 | |||
| Nikkaji | J3.190I | |||
| BindingDB | 50103595 | 22889 | 50403559 | 181119 |
| EPA CompTox Dashboard | DTXSID4020329 | |||
| DrugCentral | 645 | |||
| Brenda | 204960 | 229279 | 5306 | 229278 |
| ChemicalBook | CB31086794 | CB4229414 | ||
| Guide to Pharmacology | 1231 | |||
| rxnorm | CIMETIDINE | TAGAMET | CIMETIDINE HYDROCHLORIDE | |
| PubChem: Drugs of the Future | 12013445 | |||
| KEGG Ligand | C06952 | |||
| ChEBI | 3699 | |||
| ZINC | ZINC000018115268 |
